Neil M. Bressler

Neil M. Bressler's AcademicInfluence.com Rankings

Neil M. Bressler

Medical

#1271

World Rank

#1593

Historical Rank

Ophthalmology

#19

World Rank

#27

Historical Rank

medical Degrees

Download Badge

Medical

Why Is Neil M. Bressler Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Neil M. Bressler's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: two-year results of 2 randomized clinical trials-tap report 2. (2001) (2030)
An international classification and grading system for age-related maculopathy and age-related macular degeneration. The International ARM Epidemiological Study Group. (1995) (1890)
Development and Validation of a Deep Learning System for Diabetic Retinopathy and Related Eye Diseases Using Retinal Images From Multiethnic Populations With Diabetes (2017) (1201)
Aflibercept, bevacizumab, or ranibizumab for diabetic macular edema. (2015) (1034)
Verteporfin therapy of subfoveal choroidal neovascularization in age-related macular degeneration: two-year results of a randomized clinical trial including lesions with occult with no classic choroidal neovascularization-verteporfin in photodynamic therapy report 2. (2002) (738)
Aflibercept, Bevacizumab, or Ranibizumab for Diabetic Macular Edema: Two-Year Results from a Comparative Effectiveness Randomized Clinical Trial. (2016) (691)
A phase II randomized double-masked trial of pegaptanib, an anti-vascular endothelial growth factor aptamer, for diabetic macular edema. (2005) (584)
Panretinal Photocoagulation vs Intravitreous Ranibizumab for Proliferative Diabetic Retinopathy: A Randomized Clinical Trial. (2015) (566)
The long-term effects of visible light on the eye. (1992) (561)
Expanded 2-year follow-up of ranibizumab plus prompt or deferred laser or triamcinolone plus prompt laser for diabetic macular edema. (2011) (531)
Relationship between optical coherence tomography-measured central retinal thickness and visual acuity in diabetic macular edema. (2007) (518)
Photodynamic therapy of subfoveal choroidal neovascularization in pathologic myopia with verteporfin. 1-year results of a randomized clinical trial--VIP report no. 1. (2001) (500)
Intravitreal Ranibizumab for diabetic macular edema with prompt versus deferred laser treatment: 5-year randomized trial results. (2015) (482)
The Age-Related Eye Disease Study (AREDS): design implications. AREDS report no. 1. (1999) (470)
A phase II randomized clinical trial of intravitreal bevacizumab for diabetic macular edema. (2007) (440)
Three-year follow-up of a randomized trial comparing focal/grid photocoagulation and intravitreal triamcinolone for diabetic macular edema. (2009) (393)
Photodynamic therapy with verteporfin for choroidal neovascularization caused by age-related macular degeneration: results of a single treatment in a phase 1 and 2 study. (1999) (387)
Automated Grading of Age-Related Macular Degeneration From Color Fundus Images Using Deep Convolutional Neural Networks (2017) (378)
Age-related macular degeneration is the leading cause of blindness... (2004) (370)
Verteporfin therapy of subfoveal choroidal neovascularization in pathologic myopia: 2-year results of a randomized clinical trial--VIP report no. 3. (2003) (370)
Intravitreal ranibizumab for diabetic macular edema with prompt versus deferred laser treatment: three-year randomized trial results. (2012) (357)
Potential public health impact of Age-Related Eye Disease Study results: AREDS report no. 11. (2003) (341)
Relationship of drusen and abnormalities of the retinal pigment epithelium to the prognosis of neovascular macular degeneration. The Macular Photocoagulation Study Group. (1990) (322)
Frequency of adverse systemic reactions after fluorescein angiography. Results of a prospective study. (1991) (312)
Prevalence of and risk factors for diabetic macular edema in the United States. (2014) (292)
Exposure to sunlight and other risk factors for age-related macular degeneration. (1989) (268)
Racial differences in the prevalence of age-related macular degeneration: the Baltimore Eye Survey. (1999) (267)
Vitrectomy outcomes in eyes with diabetic macular edema and vitreomacular traction. (2010) (263)
Retinal arteriolar narrowing and risk of coronary heart disease. (2003) (257)
Effect of lesion size, visual acuity, and lesion composition on visual acuity change with and without verteporfin therapy for choroidal neovascularization secondary to age-related macular degeneration: TAP and VIP report no. 1. (2003) (255)
Surgery for hemorrhagic choroidal neovascular lesions of age-related macular degeneration: ophthalmic findings: SST report no. 13. (2004) (253)
The grading and prevalence of macular degeneration in Chesapeake Bay watermen. (1989) (252)
Changes in retinal neovascularization after pegaptanib (Macugen) therapy in diabetic individuals. (2006) (249)
Krypton laser photocoagulation for neovascular lesions of age-related macular degeneration. Results of a randomized clinical trial. Macular Photocoagulation Study Group. (1990) (243)
Analysis of macular edema after cataract surgery in patients with diabetes using optical coherence tomography. (2007) (243)
Natural course of choroidal neovascular membranes within the foveal avascular zone in senile macular degeneration. (1982) (235)
Deep learning in ophthalmology: The technical and clinical considerations (2019) (233)
Improved vision-related function after ranibizumab treatment of neovascular age-related macular degeneration: results of a randomized clinical trial. (2007) (226)
Detection of diabetic foveal edema: contact lens biomicroscopy compared with optical coherence tomography. (2004) (224)
Efficacy and Safety of Lampalizumab for Geographic Atrophy Due to Age-Related Macular Degeneration: Chroma and Spectri Phase 3 Randomized Clinical Trials (2018) (221)
Visible light and risk of age-related macular degeneration. (1990) (219)
Five-Year Outcomes of Panretinal Photocoagulation vs Intravitreous Ranibizumab for Proliferative Diabetic Retinopathy: A Randomized Clinical Trial (2018) (217)
A preliminary study of photodynamic therapy using verteporfin for choroidal neovascularization in pathologic myopia, ocular histoplasmosis syndrome, angioid streaks, and idiopathic causes. (2000) (212)
The long-term natural history of geographic atrophy from age-related macular degeneration: enlargement of atrophy and implications for interventional clinical trials. (2007) (207)
Artificial Intelligence With Deep Learning Technology Looks Into Diabetic Retinopathy Screening. (2016) (199)
Verteporfin therapy of subfoveal minimally classic choroidal neovascularization in age-related macular degeneration: 2-year results of a randomized clinical trial. (2005) (198)
Photodynamic therapy with verteporfin for choroidal neovascularization caused by age-related macular degeneration: results of retreatments in a phase 1 and 2 study. (1999) (197)
Five-year incidence and disappearance of drusen and retinal pigment epithelial abnormalities. Waterman study. (1995) (192)
Photodynamic therapy of subfoveal choroidal neovascularization with verteporfin: fluorescein angiographic guidelines for evaluation and treatment--TAP and VIP report No. 2. (2003) (186)
Translocation of the retina for management of subfoveal choroidal neovascularization II : A preliminary report in humans (1998) (183)
Persistent Macular Thickening Following Intravitreous Aflibercept, Bevacizumab, or Ranibizumab for Central-Involved Diabetic Macular Edema With Vision Impairment: A Secondary Analysis of a Randomized Clinical Trial (2018) (180)
CLINICOPATHOLOGIC CORRELATION OF DRUSEN AND RETINAL PIGMENT EPITHELIAL ABNORMALITIES IN AGE-RELATED MACULAR DEGENERATION (2005) (177)
Verteporfin therapy of subfoveal choroidal neovascularization in patients with age-related macular degeneration: additional information regarding baseline lesion composition's impact on vision outcomes-TAP report No. 3. (2002) (169)
Verteporfin therapy for subfoveal choroidal neovascularization in age-related macular degeneration: four-year results of an open-label extension of 2 randomized clinical trials: TAP Report No. 7. (2002) (166)
Surgery for subfoveal choroidal neovascularization in age-related macular degeneration: ophthalmic findings: SST report no. 11. (2004) (164)
Are antioxidants or supplements protective for age-related macular degeneration? (1994) (164)
Validating retinal fundus image analysis algorithms: issues and a proposal. (2013) (164)
Risk of endophthalmitis after intravitreal drug injection when topical antibiotics are not required: the diabetic retinopathy clinical research network laser-ranibizumab-triamcinolone clinical trials. (2009) (162)
Reproducibility of macular thickness and volume using Zeiss optical coherence tomography in patients with diabetic macular edema. (2007) (159)
Comparing humans and deep learning performance for grading AMD: A study in using universal deep features and transfer learning for automated AMD analysis (2017) (158)
Natural course of poorly defined choroidal neovascularization associated with macular degeneration. (1988) (156)
Occult choroidal neovascularization. Influence on visual outcome in patients with age-related macular degeneration. Macular Photocoagulation Study Group. (1996) (152)
Effect of Adding Dexamethasone to Continued Ranibizumab Treatment in Patients With Persistent Diabetic Macular Edema: A DRCR Network Phase 2 Randomized Clinical Trial (2018) (150)
Optical coherence tomography measurements and analysis methods in optical coherence tomography studies of diabetic macular edema. (2008) (149)
Cost-effectiveness of Aflibercept, Bevacizumab, and Ranibizumab for Diabetic Macular Edema Treatment: Analysis From the Diabetic Retinopathy Clinical Research Network Comparative Effectiveness Trial. (2016) (149)
Improved vision-related function after ranibizumab for macular edema after retinal vein occlusion: results from the BRAVO and CRUISE trials. (2012) (148)
Low luminance visual dysfunction as a predictor of subsequent visual acuity loss from geographic atrophy in age-related macular degeneration. (2008) (147)
Photodynamic therapy with verteporfin (Visudyne): impact on ophthalmology and visual sciences. (2000) (141)
Photodynamic therapy of subfoveal choroidal neovascularization: clinical and angiographic examples (1998) (140)
Persistent Macular Thickening After Ranibizumab Treatment for Diabetic Macular Edema With Vision Impairment. (2016) (140)
Acute severe visual acuity decrease after photodynamic therapy with verteporfin: case reports from randomized clinical trials-TAP and VIP report no. 3. (2004) (139)
Measuring geographic atrophy in advanced age-related macular degeneration. (1999) (139)
The development of choroidal neovascularization in eyes with the geographic atrophy form of age-related macular degeneration. (1999) (133)
Visual acuity as an outcome measure in clinical trials of retinal diseases. (2007) (132)
Retinal thickness in people with diabetes and minimal or no diabetic retinopathy: Heidelberg Spectralis optical coherence tomography. (2012) (130)
Vision-related function after ranibizumab treatment by better- or worse-seeing eye: clinical trial results from MARINA and ANCHOR. (2010) (130)
Responsiveness of NEI VFQ-25 to changes in visual acuity in neovascular AMD: validation studies from two phase 3 clinical trials. (2009) (129)
Clinical characteristics of choroidal neovascular membranes. (1987) (128)
Deep Learning based Retinal OCT Segmentation (2018) (128)
Five-Year Outcomes of Ranibizumab With Prompt or Deferred Laser Versus Laser or Triamcinolone Plus Deferred Ranibizumab for Diabetic Macular Edema. (2016) (127)
Public Attitudes About Eye and Vision Health. (2016) (126)
AI for medical imaging goes deep (2018) (126)
Antiangiogenic approaches to age-related macular degeneration today. (2009) (123)
Histopathologic and ultrastructural features of surgically excised subfoveal choroidal neovascular lesions: submacular surgery trials report no. 7. (2005) (123)
RANDOMIZED TRIAL EVALUATING SHORT-TERM EFFECTS OF INTRAVITREAL RANIBIZUMAB OR TRIAMCINOLONE ACETONIDE ON MACULAR EDEMA AFTER FOCAL/GRID LASER FOR DIABETIC MACULAR EDEMA IN EYES ALSO RECEIVING PANRETINAL PHOTOCOAGULATION (2011) (123)
Diabetic macular edema: what is focal and what is diffuse? (2008) (121)
Aflibercept, bevacizumab or ranibizumab for diabetic macular oedema: recent clinically relevant findings from DRCR.net Protocol T (2017) (121)
Occult choroidal neovascularization in age-related macular degeneration. A natural history study. (1997) (119)
Photodynamic therapy for focal retinal pigment epithelial leaks secondary to central serous chorioretinopathy. (2005) (119)
Submacular surgery trials randomized pilot trial of laser photocoagulation versus surgery for recurrent choroidal neovascularization secondary to age-related macular degeneration: I. Ophthalmic outcomes submacular surgery trials pilot study report number 1. (2000) (118)
Laser treatment of choroidal neovascularization in patients with angioid streaks. (1993) (116)
GUIDELINES FOR USING VERTEPORFIN (VISUDYNE) IN PHOTODYNAMIC THERAPY FOR CHOROIDAL NEOVASCULARIZATION DUE TO AGE-RELATED MACULAR DEGENERATION AND OTHER CAUSES: UPDATE (2005) (115)
Rationale for the diabetic retinopathy clinical research network treatment protocol for center-involved diabetic macular edema. (2011) (114)
Randomized trial of peribulbar triamcinolone acetonide with and without focal photocoagulation for mild diabetic macular edema: a pilot study. (2007) (113)
Use of Deep Learning for Detailed Severity Characterization and Estimation of 5-Year Risk Among Patients With Age-Related Macular Degeneration (2018) (113)
Estimated cases of legal blindness and visual impairment avoided using ranibizumab for choroidal neovascularization: non-Hispanic white population in the United States with age-related macular degeneration. (2011) (113)
Observational study of the development of diabetic macular edema following panretinal (scatter) photocoagulation given in 1 or 4 sittings. (2009) (113)
Responsiveness of the National Eye Institute Visual Function Questionnaire to changes in visual acuity: findings in patients with subfoveal choroidal neovascularization--SST Report No. 1. (2003) (110)
FACTORS ASSOCIATED WITH VISUAL ACUITY OUTCOMES AFTER VITRECTOMY FOR DIABETIC MACULAR EDEMA: Diabetic Retinopathy Clinical Research Network (2010) (109)
Retinal thickness on Stratus optical coherence tomography in people with diabetes and minimal or no diabetic retinopathy. (2008) (108)
Improved vision-related function after ranibizumab vs photodynamic therapy: a randomized clinical trial. (2009) (104)
A METHOD OF REPORTING MACULAR EDEMA AFTER CATARACT SURGERY USING OPTICAL COHERENCE TOMOGRAPHY (2008) (104)
Macular edema after cataract surgery in eyes without preoperative central-involved diabetic macular edema. (2013) (103)
Factors associated with improvement and worsening of visual acuity 2 years after focal/grid photocoagulation for diabetic macular edema. (2010) (103)
Exploratory analysis of the effect of intravitreal ranibizumab or triamcinolone on worsening of diabetic retinopathy in a randomized clinical trial. (2013) (101)
Progression of Geographic Atrophy in Age-related Macular Degeneration: AREDS2 Report Number 16. (2018) (100)
Translocation of the retina for management of subfoveal choroidal neovascularization II: a preliminary report in humans. (1998) (96)
Comparison of Early Treatment Diabetic Retinopathy Study Standard 7-Field Imaging With Ultrawide-Field Imaging for Determining Severity of Diabetic Retinopathy (2019) (95)
CLINICOPATHOLOGIC CORRELATION OF THE MULTIPLE RECURRENT SEROSANGUINEOUS RETINAL PIGMENT EPITHELIAL DETACHMENTS SYNDROME (1994) (94)
Verteporfin therapy for subfoveal choroidal neovascularization in age-related macular degeneration: three-year results of an open-label extension of 2 randomized clinical trials--TAP Report no. 5. (2002) (93)
Preferential Hyperacuity Perimeter (PreView PHP) for detecting choroidal neovascularization study. (2005) (91)
Assessment of Deep Generative Models for High-Resolution Synthetic Retinal Image Generation of Age-Related Macular Degeneration (2019) (91)
Detection of age-related macular degeneration via deep learning (2016) (90)
Comparison of Aflibercept, Bevacizumab, and Ranibizumab for Treatment of Diabetic Macular Edema: Extrapolation of Data to Clinical Practice. (2016) (90)
Scanning laser ophthalmoscopic analysis of the pattern of visual loss in age-related geographic atrophy of the macula. (1995) (90)
RESULTS OF A MULTICENTER CLINICAL TRIAL TO EVALUATE THE PREFERENTIAL HYPERACUITY PERIMETER FOR DETECTION OF AGE-RELATED MACULAR DEGENERATION (2005) (89)
Persistent and recurrent neovascularization after krypton laser kphotocoagualation for neovascular lesions fo age-related macular degenration (1990) (89)
Japanese age-related macular degeneration trial: 1-year results of photodynamic therapy with verteporfin in Japanese patients with subfoveal choroidal neovascularization secondary to age-related macular degeneration. (2003) (87)
Randomized clinical trial evaluating intravitreal ranibizumab or saline for vitreous hemorrhage from proliferative diabetic retinopathy. (2013) (87)
Health- and vision-related quality of life among patients with choroidal neovascularization secondary to age-related macular degeneration at enrollment in randomized trials of submacular surgery: SST report no. 4. (2004) (87)
EFFECTS OF VERTEPORFIN THERAPY ON CONTRAST SENSITIVITY: Results From the Treatment of Age-Related Macular Degeneration With Photodynamic Therapy (TAP) Investigation—TAP Report No. 4 (2002) (86)
ADULT‐ONSET FOVEOMACULAR PIGMENT EPITHELIAL DYSTROPHY: Clinicopathologic Correlation of Three Cases (2000) (85)
Exploratory analysis of diabetic retinopathy progression through 3 years in a randomized clinical trial that compares intravitreal triamcinolone acetonide with focal/grid photocoagulation. (2009) (85)
Diminished foveal sensitivity may predict the development of advanced age-related macular degeneration. (1989) (85)
Verteporfin therapy of subfoveal choroidal neovascularization in age-related macular degeneration: meta-analysis of 2-year safety results in three randomized clinical trials: Treatment Of Age-Related Macular Degeneration With Photodynamic Therapy and Verteporfin In Photodynamic Therapy Study Report (2004) (84)
CEREBROVASCULAR ACCIDENTS IN PATIENTS TREATED FOR CHOROIDAL NEOVASCULARIZATION WITH RANIBIZUMAB IN RANDOMIZED CONTROLLED TRIALS (2012) (83)
Early detection and treatment of neovascular age-related macular degeneration. (2002) (83)
Drusen characteristics in patients with exudative versus non-exudative age-related macular degeneration. (1988) (83)
Update on risk of endophthalmitis after intravitreal drug injections and potential impact of elimination of topical antibiotics. (2012) (81)
Clinicopathologic Correlation of Occult Choroidal Neovascularization in Age-Related Macular Degeneration (1992) (81)
Comparison of time-domain OCT and fundus photographic assessments of retinal thickening in eyes with diabetic macular edema. (2008) (81)
Reproducibility of spectral-domain optical coherence tomography retinal thickness measurements and conversion to equivalent time-domain metrics in diabetic macular edema. (2014) (81)
Optical coherence tomography and cataract surgery (2009) (80)
Underuse of the health care system by persons with diabetes mellitus and diabetic macular edema in the United States. (2014) (77)
Cigarette smoking and risk for progression of nuclear opacities. (1995) (77)
Clinicopathologic correlation of drusen and retinal pigment epithelial abnormalities in age-related macular degeneration. 1994. (2005) (76)
Detection of new-onset choroidal neovascularization using optical coherence tomography: the AMD DOC Study. (2012) (75)
Preventative ophthalmology. Age-related macular degeneration. (1995) (75)
Photodynamic therapy of subfoveal choroidal neovascularization with verteporfin in the ocular histoplasmosis syndrome: one-year results of an uncontrolled, prospective case series. (2002) (74)
Surgery for subfoveal choroidal neovascularization in age-related macular degeneration: quality-of-life findings: SST report no. 12. (2004) (73)
Cortical lenticular opacification: distribution and location in a longitudinal study. (1994) (71)
Comparison of Prevalence of Diabetic Macular Edema Based on Monocular Fundus Photography vs Optical Coherence Tomography. (2016) (70)
RANIBIZUMAB PLUS PROMPT OR DEFERRED LASER FOR DIABETIC MACULAR EDEMA IN EYES WITH VITRECTOMY BEFORE ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR THERAPY (2015) (70)
Panretinal photocoagulation for proliferative diabetic retinopathy. (2011) (68)
Agreement of time-domain and spectral-domain optical coherence tomography with fluorescein leakage from choroidal neovascularization. (2010) (67)
Rationale and Application of the Protocol S Anti-Vascular Endothelial Growth Factor Algorithm for Proliferative Diabetic Retinopathy. (2019) (67)
Concurrent studies of oxygen consumption and aggregation in stimulated human platelets. (1979) (67)
Repeated intravitreous ranibizumab injections for diabetic macular edema and the risk of sustained elevation of intraocular pressure or the need for ocular hypotensive treatment. (2015) (67)
Association of Baseline Visual Acuity and Retinal Thickness With 1-Year Efficacy of Aflibercept, Bevacizumab, and Ranibizumab for Diabetic Macular Edema. (2016) (66)
Surgical removal vs observation for subfoveal choroidal neovascularization, either associated with the ocular histoplasmosis syndrome or idiopathic: I. Ophthalmic findings from a randomized clinical trial: Submacular Surgery Trials (SST) Group H Trial: SST Report No. 9. (2004) (66)
PROSPECTIVE ONE-YEAR STUDY OF RANIBIZUMAB FOR PREDOMINANTLY HEMORRHAGIC CHOROIDAL NEOVASCULAR LESIONS IN AGE-RELATED MACULAR DEGENERATION (2010) (64)
Association Between Change in Visual Acuity and Change in Central Subfield Thickness During Treatment of Diabetic Macular Edema in Participants Randomized to Aflibercept, Bevacizumab, or Ranibizumab: A Post Hoc Analysis of the Protocol T Randomized Clinical Trial. (2019) (61)
The use of fundus photographs and fluorescein angiograms in the identification and treatment of choroidal neovascularization in the Macular Photocoagulation Study. The Macular Photocoagulation Study Group. (1989) (59)
Early Response to Anti-Vascular Endothelial Growth Factor and Two-Year Outcomes Among Eyes With Diabetic Macular Edema in Protocol T. (2018) (59)
TOPICAL NEPAFENEC IN EYES WITH NONCENTRAL DIABETIC MACULAR EDEMA (2015) (58)
Evaluation of Minimum Clinically Meaningful Changes in Scores on the National Eye Institute Visual Function Questionnaire (NEI-VFQ) SST Report Number 19 (2007) (57)
Automated detection of drusen in the macula (2009) (57)
Automated segmentation of geographic atrophy of the retinal epithelium via random forests in AREDS color fundus images (2015) (56)
Cost-effectiveness of Intravitreous Ranibizumab Compared With Panretinal Photocoagulation for Proliferative Diabetic Retinopathy: Secondary Analysis From a Diabetic Retinopathy Clinical Research Network Randomized Clinical Trial (2017) (56)
Vision-related function after ranibizumab treatment for diabetic macular edema: results from RIDE and RISE. (2014) (56)
Treatment of subfoveal choroidal neovascularisation in age related macular degeneration: focus on clinical application of verteporfin photodynamic therapy (2001) (55)
Retinal pigment epithelial tears through the fovea with preservation of good visual acuity. (1990) (55)
Does laser still have a role in the management of retinal vascular and neovascular diseases? (2011) (55)
Observational study of subclinical diabetic macular edema (2010) (55)
Relative contributions of reduced vision and general health to NEI-VFQ scores in patients with neovascular age-related macular degeneration. (2004) (54)
Photodynamic therapy with verteporfin in ocular histoplasmosis: uncontrolled, open-label 2-year study. (2004) (54)
Use of patient-reported outcomes in medical product development: a report from the 2009 NEI/FDA Clinical Trial Endpoints Symposium. (2010) (53)
Surgery for cataracts in people with age-related macular degeneration. (2017) (53)
Surgery for hemorrhagic choroidal neovascular lesions of age-related macular degeneration: quality-of-life findings: SST report no. 14. (2004) (52)
EFFECT OF FOCAL/GRID PHOTOCOAGULATION ON VISUAL ACUITY AND RETINAL THICKENING IN EYES WITH NON–CENTER-INVOLVED DIABETIC MACULAR EDEMA (2009) (52)
Radiation retinopathy after fractionated stereotactic radiotherapy for optic nerve sheath meningioma. (2004) (51)
Impact of availability of anti-vascular endothelial growth factor therapy on visual impairment and blindness due to neovascular age-related macular degeneration. (2012) (51)
Measurement and Reproducibility of Preserved Ellipsoid Zone Area and Preserved Retinal Pigment Epithelium Area in Eyes With Choroideremia. (2017) (50)
Estimated Cases of Blindness and Visual Impairment from Neovascular Age-Related Macular Degeneration Avoided in Australia by Ranibizumab Treatment (2014) (50)
Sudden visual loss associated with sexual activity. (1995) (48)
Incident choroidal neovascularization in fellow eyes of patients with unilateral subfoveal choroidal neovascularization secondary to age-related macular degeneration: SST report No. 20 from the Submacular Surgery Trials Research Group. (2007) (47)
Submacular surgery. Are randomized trials necessary? (1995) (47)
Patient-reported visual function outcomes improve after ranibizumab treatment in patients with vision impairment due to diabetic macular edema: randomized clinical trial. (2013) (47)
Anti-Vascular Endothelial Growth Factor Comparative Effectiveness Trial for Diabetic Macular Edema: Additional Efficacy Post Hoc Analyses of a Randomized Clinical Trial. (2016) (46)
Validation of the National Eye Institute Visual Function Questionnaire-25 (NEI VFQ-25) in age-related macular degeneration. (2011) (46)
Revolution to a new standard treatment of diabetic macular edema. (2014) (46)
Laser treatment for subfoveal neovascular membranes in ocular histoplasmosis syndrome: results of a pilot randomized clinical trial. (1993) (45)
Long-term safety and efficacy of patisiran for hereditary transthyretin-mediated amyloidosis with polyneuropathy: 12-month results of an open-label extension study (2020) (45)
Automated classification of severity of age-related macular degeneration from fundus photographs. (2013) (44)
Development of a preference-based index from the National Eye Institute Visual Function Questionnaire-25. (2014) (44)
Comparison of film and digital fundus photographs in eyes of individuals with diabetes mellitus. (2011) (44)
Diabetic Macular Edema: Current and Emerging Therapies (2012) (43)
SUBFOVEAL NEOVASCULAR MEMBRANES IN SENILE MACULAR DEGENERATION: Relationship Between Membrane Size and Visual Prognosis (1983) (43)
Automatic screening of age-related macular degeneration and retinal abnormalities (2011) (43)
Use of best and final visual acuity outcomes in ophthalmological research. (2003) (42)
Ketorolac treatment of pseudophakic cystoid macular edema identified more than 24 months after cataract extraction. (1999) (41)
Surgical removal vs observation for subfoveal choroidal neovascularization, either associated with the ocular histoplasmosis syndrome or idiopathic: II. Quality-of-life findings from a randomized clinical trial: SST Group H Trial: SST Report No. 10. (2004) (41)
Rasch analysis in the development of a simplified version of the national eye institute visual-function questionnaire-25 for utility estimation (2012) (40)
Utility of Deep Learning Methods for Referability Classification of Age-Related Macular Degeneration (2018) (39)
Chapter 60 – Age-Related Macular Degeneration: Nonneovascular Early AMD, Intermediate AMD, and Geographic Atrophy (2006) (37)
Panretinal Photocoagulation Versus Ranibizumab for Proliferative Diabetic Retinopathy: Patient-Centered Outcomes From a Randomized Clinical Trial. (2016) (37)
Macular scatter ('grid') laser treatment of poorly demarcated subfoveal choroidal neovascularization in age-related macular degeneration. Results of a randomized pilot trial. (1996) (36)
Five-year follow-up of fellow eyes of individuals with ocular histoplasmosis and unilateral extrafoveal or juxtafoveal choroidal neovascularization (1996) (34)
MARINA STUDY GROUP. IMPROVED VISION-RELATED FUNCTION AFTER RANIBIZUMAB TREATMENT OF NEOVASCULAR AGE-RELATED MACULAR DEGENERATION: RESULTS OF A RANDOMIZED CLINICAL TRIAL (2007) (34)
Sensitivity and Specificity of Potential Diagnostic Features Detected Using Fundus Photography, Optical Coherence Tomography, and Fluorescein Angiography for Polypoidal Choroidal Vasculopathy. (2019) (34)
Recent clinically relevant highlights from the Diabetic Retinopathy Clinical Research Network (2018) (34)
Scanning laser ophthalmoscope fundus perimetry after surgery for choroidal neovascularization. (1998) (34)
How Should Journals Handle the Conflict of Interest of Their Editors?: Who Watches the "Watchers"? (2017) (33)
Reliability and Construct Validity of the NEI VFQ-25 in a Subset of Patients With Geographic Atrophy From the Phase 2 Mahalo Study. (2018) (33)
Retinal anastomosis to choroidal neovascularization: a bum rap for a difficult disease. (2005) (33)
DESIGNING CLINICAL TRIALS FOR AGE-RELATED GEOGRAPHIC ATROPHY OF THE MACULA: Enrollment Data From the Geographic Atrophy Natural History Study (2006) (33)
Low-Shot Deep Learning of Diabetic Retinopathy With Potential Applications to Address Artificial Intelligence Bias in Retinal Diagnostics and Rare Ophthalmic Diseases. (2020) (33)
Efficacy and Safety of a Proposed Ranibizumab Biosimilar Product vs a Reference Ranibizumab Product for Patients With Neovascular Age-Related Macular Degeneration (2020) (32)
Photodynamic therapy with verteporfin for subfoveal choroidal neovascularization in children. (2003) (31)
OCULAR SIDE EFFECTS ASSOCIATED WITH PERIBULBAR INJECTIONS OF TRIAMCINOLONE ACETONIDE FOR DIABETIC MACULAR EDEMA (2011) (31)
Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: One-year results of two randomized clinical trials (2000) (31)
Vitamin usage patterns in the prevention of advanced age-related macular degeneration. (2008) (31)
Addressing Artificial Intelligence Bias in Retinal Diagnostics (2021) (31)
Choroidal neovascularization in black patients. (1994) (30)
Agreement between clinician and reading center gradings of diabetic retinopathy severity level at baseline in a phase 2 study of intravitreal bevacizumab for diabetic macular edema. (2008) (30)
Age-related macular degeneration. (1988) (30)
Natural History of Drusenoid Pigment Epithelial Detachment Associated with Age-Related Macular Degeneration: Age-Related Eye Disease Study 2 Report No. 17. (2019) (30)
Assessing the Effect of Personalized Diabetes Risk Assessments During Ophthalmologic Visits on Glycemic Control: A Randomized Clinical Trial. (2015) (29)
Progression of age-related macular degeneration after cataract surgery. (2009) (29)
Clinicopathologic studies of eyes that were obtained postmortem from four patients who were enrolled in the submacular surgery trials: SST Report No. 16. (2006) (28)
Functional Reading Independence (FRI) Index: A New Patient-Reported Outcome Measure for Patients With Geographic Atrophy. (2017) (28)
COMPARING RETINAL THICKNESS MEASUREMENTS FROM CIRRUS SPECTRAL DOMAIN- AND STRATUS TIME DOMAIN-OPTICAL COHERENCE TOMOGRAPHY (2008) (28)
Vision-threatening lesions developing with longer-term follow-up after treatment of neovascular age-related macular degeneration. (2015) (28)
Patients' perceptions of the value of current vision: assessment of preference values among patients with subfoveal choroidal neovascularization--The Submacular Surgery Trials Vision Preference Value Scale: SST Report No. 6. (2004) (27)
Occult with no classic subfoveal choroidal neovascular lesions in age-related macular degeneration: clinically relevant natural history information in larger lesions with good vision from the Verteporfin in Photodynamic Therapy (VIP) Trial: VIP Report No. 4. (2006) (26)
Development of a new Rasch-based scoring algorithm for the National Eye Institute Visual Functioning Questionnaire to improve its interpretability (2017) (26)
RISK FACTORS FOR SECOND EYE PROGRESSION TO ADVANCED AGE-RELATED MACULAR DEGENERATION: SST Report No. 21 Submacular Surgery Trials Research Group (2009) (26)
Plasma Vascular Endothelial Growth Factor Concentrations after Intravitreous Anti-Vascular Endothelial Growth Factor Therapy for Diabetic Macular Edema. (2018) (25)
Management of macular edema from retinal vein occlusions: you can never have too many choices. (2010) (25)
Death by Gun Violence-A Public Health Crisis. (2017) (25)
Natural history of minimally classic subfoveal choroidal neovascular lesions in the treatment of age-related macular degeneration with photodynamic therapy (TAP) investigation: outcomes potentially relevant to management--TAP report No. 6. (2004) (25)
A COST-EFFECTIVENESS ANALYSIS OF THREE TREATMENTS FOR AGE-RELATED MACULAR DEGENERATION (2010) (25)
Visual Field Changes Over 5 Years in Patients Treated With Panretinal Photocoagulation or Ranibizumab for Proliferative Diabetic Retinopathy. (2020) (25)
Five-Year Cost-effectiveness of Intravitreous Ranibizumab Therapy vs Panretinal Photocoagulation for Treating Proliferative Diabetic Retinopathy: A Secondary Analysis of a Randomized Clinical Trial. (2019) (24)
Chapter 61 – Neovascular (Exudative) Age-Related Macular Degeneration (2005) (24)
ASSOCIATION OF FLUORESCEIN ANGIOGRAPHIC FEATURES WITH VISUAL ACUITY AND WITH OPTICAL COHERENCE TOMOGRAPHIC AND STEREOSCOPIC COLOR FUNDUS PHOTOGRAPHIC FEATURES OF DIABETIC MACULAR EDEMA IN A RANDOMIZED CLINICAL TRIAL (2010) (24)
Death by Gun Violence-A Public Health Crisis. (2017) (24)
Visual Impairment and Blindness Avoided with Ranibizumab in Hispanic and Non-Hispanic Whites with Diabetic Macular Edema in the United States. (2015) (23)
Assessment of the DRCR Retina Network Approach to Management With Initial Observation for Eyes With Center-Involved Diabetic Macular Edema and Good Visual Acuity: A Secondary Analysis of a Randomized Clinical Trial. (2020) (23)
GUIDELINES FOR INTERPRETING RETINAL PHOTOGRAPHS AND CODING FINDINGS IN THE SUBMACULAR SURGERY TRIALS (SST): SST Report No. 8 (2005) (22)
Color Fundus Photography, Optical Coherence Tomography, and Fluorescein Angiography in Diagnosing Polypoidal Choroidal Vasculopathy. (2018) (22)
Submacular surgery. New information, more questions. (1997) (21)
Loculated fluid. A previously undescribed fluorescein angiographic finding in choroidal neovascularization associated with macular degeneration. Macular Photocoagulation Study Reading Center. (1991) (21)
Reading speed improvements in retinal vein occlusion after ranibizumab treatment. (2013) (21)
RETROSPECTIVE CASE SERIES OF JUXTAFOVEAL CHOROIDAL NEOVASCULARIZATION TREATED WITH PHOTODYNAMIC THERAPY WITH VERTEPORFIN (2004) (21)
Hemoglobin A1c awareness among patients receiving eye care at a tertiary ophthalmic center. (2004) (21)
Three-year patient-reported visual function outcomes in diabetic macular edema managed with ranibizumab: the RESTORE extension study (2015) (21)
Effect of Ranibizumab on the Decision to Drive and Vision Function Relevant to Driving in Patients With Diabetic Macular Edema: Report From RESTORE, RIDE, and RISE Trials. (2016) (20)
Interobserver and intraobserver reliability in the clinical classification of drusen. (1988) (20)
Age related macular degeneration (2000) (20)
GREEN OR YELLOW LASER TREATMENT FOR DIABETIC MACULAR EDEMA: Exploratory Assessment Within the Diabetic Retinopathy Clinical Research Network (2013) (19)
Photodynamic therapy with verteporfin for choroidal neovascularization in patients with diabetic retinopathy. (2001) (19)
Detection of diabetic macular edema: Nidek 3Dx stereophotography compared with fundus biomicroscopy. (1996) (19)
Large submacular hemorrhages after verteporfin therapy. (2004) (19)
PATIENTS’ PREFERENCES IN CHOOSING THERAPY FOR RETINAL VEIN OCCLUSIONS (2006) (18)
Use of best and final visual acuity outcomes in ophthalmological research (2004) (17)
Repeatability and Agreement of Visual Acuity Using the ETDRS Number Chart, Landolt C Chart, or ETDRS Alphabet Chart in Eyes With or Without Sight-Threatening Diseases (2018) (17)
Equity and the JAMA Network. (2021) (17)
Driving ability reported by neovascular age-related macular degeneration patients after treatment with ranibizumab. (2013) (17)
Neovascularization of the optic disk associated with atypical retinitis pigmentosa. (1985) (16)
New therapies for neovascular age-related macular degeneration: critical appraisal of the current evidence. (2006) (16)
Death by Gun Violence-A Public Health Crisis. (2017) (16)
Visual Acuity Reporting in Clinical Research Publications (2017) (16)
Comparison of time- and spectral-domain optical coherence tomography in management of diabetic macular edema. (2014) (16)
The role of laser wavelength in the treatment of vitreoretinal diseases (1994) (16)
Reviewers, authors, and editors: balance of power. (1999) (16)
Recent approaches to evaluating and monitoring geographic atrophy (2016) (16)
S cone pathway sensitivity in eyes with high risk and low risk drusen characteristics. (1989) (16)
Pilot study of individuals with diabetic macular edema undergoing cataract surgery. (2014) (16)
RANIBIZUMAB FOR MACULAR TELANGIECTASIA TYPE 2 IN THE ABSENCE OF SUBRETINAL NEOVASCULARIZATION (2014) (15)
Treatment of Choroidal Neovascularization: Updated Information from Recent Macular Photocoagulation Study Group Reports (1995) (15)
Equity and the JAMA Network. (2021) (15)
Periocular triamcinolone and photodynamic therapy for subfoveal choroidal neovascularization in age-related macular degeneration. (2007) (14)
Comparative Effectiveness Trial for Diabetic Macular Edema: Three Comparisons for the Price of 1 Study From the Diabetic Retinopathy Clinical Research Network. (2015) (14)
Comparison of 2D reconstructions of surgically excised subfoveal choroidal neovascularization with fluorescein angiographic features: SST report No. 15. (2006) (14)
ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR THERAPY AND RISK OF TRACTION RETINAL DETACHMENT IN EYES WITH PROLIFERATIVE DIABETIC RETINOPATHY: Pooled Analysis of Five DRCR Retina Network Randomized Clinical Trials. (2020) (14)
Vision-related function after ranibizumab treatment (2008) (13)
Are the submacular surgery trials still relevant in an era of photodynamic therapy? (2001) (13)
Chapter 65 – Age-Related Macular Degeneration: Non-neovascular Early AMD, Intermediate AMD, and Geographic Atrophy (2013) (13)
IATROGENIC CHOROIDAL NEOVASCULARIZATION OCCURRING IN PATIENTS UNDERGOING MACULAR SURGERY (2002) (13)
Improvement after verteporfin therapy. (2003) (13)
Dramatic resolution of choroidal neovascular abnormalities after single aflibercept injection following years of ranibizumab use. (2013) (13)
Setting Priorities for Diabetic Retinopathy Clinical Research and Identifying Evidence Gaps. (2017) (12)
Interim Safety Data Comparing Ranibizumab With Panretinal Photocoagulation Among Participants With Proliferative Diabetic Retinopathy (2017) (12)
Addressing Artificial Intelligence Bias in Retinal Disease Diagnostics (2020) (12)
Preliminary results of photodynamic therapy for choroidal neovascularization in pathologic myopia. ocular histoplasmosis syndrome and idiopathic causes within a phase i/ii study (1997) (12)
Detecting recurrent choroidal neovascularization. Comparison of clinical examination with and without fluorescein angiography. (1994) (12)
Is adjustment of National Eye Institute Visual Function Questionnaire scores for general health necessary in randomized trials? (2004) (12)
Fellowship Match Outcomes in the U.S. from 2010-2017: Analysis of San Francisco (SF) Match. (2020) (12)
Macular spatial distribution of preserved autofluorescence in patients with choroideremia (2018) (11)
Clinical trial performance of community- vs university-based practices in the submacular surgery trials (SST): SST report no. 2. (2004) (11)
RISK FACTORS FOR RHEGMATOGENOUS RETINAL DETACHMENT IN THE SUBMACULAR SURGERY TRIALS: SST Report No. 22 (2009) (11)
Maximum Reading Speed in Patients With Geographic Atrophy Secondary to Age-Related Macular Degeneration. (2018) (11)
Expression of concern: Thakur A, Kadam R, Kompella UB. Trabecular meshwork and lens partitioning of corticosteroids: implications for elevated intraocular pressure and cataracts. Arch Ophthalmol. 2011:129(7):914-920. (2015) (10)
Verteporfin therapy of subfoveal occult choroidal neovascularization in AMD using delayed light application: one-year results of the VALIO Study. (2007) (10)
Biosimilar SB11 versus reference ranibizumab in neovascular age-related macular degeneration: 1-year phase III randomised clinical trial outcomes (2021) (10)
Photodynamic therapy with verteporfin: observations on the introduction of a new treatment into clinical practice. (2005) (10)
Randomized clinical trials in ophthalmology in 2001: twenty-fifth anniversary of the first publication from the Diabetic Retinopathy Study. (2001) (10)
Verteporfin in Photodynamic Therapy: report no. 5. (2004) (9)
Detecting Anomalies in Retinal Diseases Using Generative, Discriminative, and Self-supervised Deep Learning. (2021) (9)
Early detection of choroidal neovascularization facilitated with a home monitoring program in age-related macular degeneration. (2015) (9)
Vitrectomy surgery for impending macular hole based on optical coherence tomography. (2001) (9)
Advantages and potential dangers of presentation before publication: third in a series on editorship. (2004) (9)
Outcome of cataract operations performed to permit diagnosis, to determine eligibility for laser therapy, or to perform laser therapy of retinal disorders. (1994) (9)
PANRETINAL PHOTOCOAGULATION VERSUS RANIBIZUMAB FOR PROLIFERATIVE DIABETIC RETINOPATHY: Comparison of Peripapillary Retinal Nerve Fiber Layer Thickness in a Randomized Clinical Trial (2017) (9)
OCT Segmentation via Deep Learning: A Review of Recent Work (2018) (9)
Surgical removal vs observation for idiopathic or ocular histoplasmosis syndrome-associated subfoveal choroidal neovascularization: Vision Preference Value Scale findings from the randomized SST Group H Trial: SST Report No. 17. (2008) (8)
Chapter 66 – Neovascular (Exudative or “Wet”) Age-Related Macular Degeneration (2012) (8)
A comparison of quantitative mapping and stereoscopic fundus photography grading of retinal thickness in diabetic eyes with macular edema. (2003) (8)
Ophthalmology and COVID-19. (2020) (8)
Indocyanine green angiography. Can it help preserve the vision of our patients? (1996) (7)
Cystoid macular edema from niacin typically is not accompanied by fluorescein leakage on angiography. (2005) (7)
JAMA Ophthalmology-The Year in Review, 2019: Striving for Sex Parity in Leadership and Excellence in Publications. (2020) (7)
Visual acuity outcomes among sham vs no-treatment controls from randomized trials. (2009) (7)
Laser management of subfoveal choroidal neovascularization in age-related macular degeneration. (1993) (7)
A Hybrid Approach for Incorporating Deep Visual Features and Side Channel Information with Applications to AMD Detection (2017) (7)
Comparability of two fundus photograph reading centers in grading cytomegalovirus retinitis progression. (2004) (6)
Frequency of intraocular pressure increase within days after intravitreal triamcinolone injections in the diabetic retinopathy clinical research network. (2011) (6)
Spontaneous improvement in myopic foveoschisis (2014) (6)
Verteporfin therapy for CNV secondary to OHS. (2006) (6)
The case report. When small is beautiful. (1996) (6)
Self–Reported Vision–Specific Quality of Life at 1 Year in Patients With Neovascular Age–Related Macular Degeneration in 2 Phase Iii Randomized Clinical Trials of Ranibizumab (LucentisTm) (2006) (6)
A Phase II Placebo-Controlled, Double-Masked, Randomized Trial - Verteporfin in Minimally Classic CNV Due to AMD (VIM) (2003) (6)
Phase 1 Clinical Study of the Port Delivery System with ranibizumab for continuous treatment of neovascular age-related macular degeneration (2020) (6)
RESPONSIVENESS OF THE NATIONAL EYE INSTITUTE VISUAL FUNCTION QUESTIONNAIRE-25 TO VISUAL ACUITY GAINS IN PATIENTS WITH DIABETIC MACULAR EDEMA (2017) (6)
Qualifying to Use a Home Monitoring Device for Detection of Neovascular Age-Related Macular Degeneration. (2015) (6)
Evaluation of automated drusen detection system for fundus photographs of patients with age-related macular degeneration (2016) (6)
CHANGES IN LESION SIZE AFTER SUBMACULAR SURGERY FOR SUBFOVEAL CHOROIDAL NEOVASCULARIZATION IN THE SUBMACULAR SURGERY TRIALS PILOT STUDY (2004) (6)
Treatment of Macular Edema Due to Central Retinal Vein Occlusion: Another Score for Repackaged Bevacizumab. (2017) (6)
Natural History of Progression of Choroideremia (NIGHT) Study: Cross-Sectional Analysis of Baseline Characteristics (2018) (5)
NATURAL HISTORY OF SUBFOVEAL SUBRETINAL HEMORRHAGE IN AGERELATED MACULAR DEGENERATION (1996) (5)
Photodynamic therapy of subfoveal choroidal neovascularization using benzoporphyrin derivative: First results of a multi-center trial (1996) (5)
Evaluation of masking study participants to intravitreal injections in a randomized clinical trial. (2012) (5)
Timing of Complete Polypoidal Regression Following Intravitreous Aflibercept Treatments in Polypoidal Choroidal Vasculopathy. (2021) (5)
Controversies in artificial intelligence. (2020) (5)
Ocular Risk Factors for Developing Neovascular AMD in the Fellow Eyes of Patients with Unilateral Neovascular AMD (2004) (5)
Angiographic features and outcome of questionable recurrent choroidal neovascularization. (1995) (5)
Understanding and reporting visual acuity measurements in publications of clinical research. (2011) (5)
Effect of medically lowering intraocular pressure in glaucoma suspects with high myopia (GSHM study): study protocol for a randomized controlled trial (2020) (4)
Costs of Managing Diabetic Macular Edema with Good Visual Acuity with Aflibercept, Laser or Observation: DRCR Retina Network Protocol V. (2021) (4)
Evaluating new retinal imaging techniques. (1998) (4)
The Natural History of the Progression of Choroideremia (NIGHT) Study: Longitudinal Changes in Visual Acuity over 12 Months (2018) (4)
Death by Gun Violence-A Public Health Crisis. (2017) (4)
Effect of telephone calls from a centralized coordinating center on participant retention in a randomized clinical trial (2020) (4)
Age-Related Macular Degeneration: Drusen and Geographic Atrophy (2008) (4)
Patient-Reported Visual Function Over 24 Months in Predominantly Classic Neovascular AMD: Results From ANCHOR, a Phase III Trial of Ranibizumab and Verteporfin PDT (2007) (3)
Comparison of methods to identify incident cataract in eyes of patients with neovascular maculopathy: Submacular Surgery Trials Report No. 18. (2008) (3)
Bilateral, multiple, episodic retinal vein occlusions associated with common variable immunodeficiency. (2015) (3)
Vision-Related Function After Ranibizumab Treatment by Better- or Worse-Seeing Eye: 24 Month Results From MARINA (2007) (3)
The enlargement of geographic atrophy over time in age-related macular degeneration (1996) (3)
ATYPICAL PARAFOVEAL TELANGIECTASIS WITH SUBSEQUENT ANTERIOR AND POSTERIOR SEGMENT NEOVASCULARIZATION (1992) (3)
RECURRENCE OF VITELLIFORM LESIONS ASSOCIATED WITH TEMPORARY VISION LOSS IN BEST VITELLIFORM MACULAR DYSTROPHY. (2016) (3)
Verteporfin therapy of subfoveal choroidal neovascularization in age-related macular degeneration: Author reply (2002) (3)
Age-Related Macular Degeneration: Choroidal Neovascularization (2008) (3)
Clinicopathologic correlation of occult choroidal neovascularization in age-related macular degeneration. 1992. (2005) (3)
Reducing the Progression of Myopia. (2020) (3)
Self-Reported Perception of Driving Function Following Ranibizumab Treatment in Patients With Neovascular AMD (2007) (3)
Foveal congenital hypertrophy of the retinal pigment epithelium in the setting of geographic atrophy from age-related macular degeneration. (2003) (3)
Death by Gun Violence-A Public Health Crisis. (2017) (3)
A primate model of macular cyst. (1991) (2)
Familial exudative vitreoretinopathy associated with monocular axial myopia. (1999) (2)
Diabetic Population-Based Model to Estimate Impact of Ranibizumab on Diabetic Retinopathy Severity in Patients with Diabetic Macular Edema (2020) (2)
Self-Reported Perception of Driving Function After Ranibizumab Therapy in Patients With Neovascular Age-Related Macular Degeneration (AMD) (2008) (2)
Correlation of Change in Central Subfield Thickness and Change in Visual Acuity in Neovascular AMD: Post Hoc Analysis of VIEW 1 and 2 (2021) (2)
Impact of Ranibizumab on Patient-Reported Visual Functioning in Myopic Choroidal Neovascularization: 3- and 6-Month Results (2013) (2)
Intraretinal fibrosis in exudative diabetic macular edema after ranibizumab treatments. (2014) (2)
Equity and the JAMA Network. (2021) (2)
Biosimilar Ranibizumab (SB11) vs Reference Ranibizumab-Diving Deeper for Safety and Efficacy-Reply. (2021) (2)
Relationship Between Patient-Reported Visual Function and Visual Acuity in Subjects With Neovascular AMD (2007) (2)
Lampalizumab for geographic atrophy (GA) in age-related macular degeneration (AMD): pooled results of the Chroma and Spectri phase 3 randomized clinical trials (RCTs) (2018) (2)
Early detection and treatment of AMD (2010) (2)
Retinal pigment epithelium tumorlike lesion arising from an area treated with laser photocoagulation. (2003) (2)
Retinopathy in patients with type 1 diabetes 4 years after intensive therapy. (2000) (2)
Recurrent Choroidal Neovascularization Following Successful Photocoagulation in Age-Related Macular Degeneration (1987) (2)
Ocular features associated with anticardiolipin antibodies: a descriptive study: Author reply (2002) (2)
Choroidal neovascularization after central retinal vein occlusion in a 47-year-old man. (2004) (2)
Death by Gun Violence-A Public Health Crisis. (2017) (2)
Equity and the JAMA Network. (2021) (2)
Public Access to Scientific Research Findings and Principles of Biomedical Research-A New Policy for the JAMA Network. (2023) (2)
Panretinal Photocoagulation vs Intravitreous Ranibizumab for Proliferative Diabetic Retinopathy: A Randomized Clinical Trial (2017) (2)
The Ocular Hypertension Treatment Study Intraocular Pressure Lowering Prevents the Development of Glaucoma, but Does That Mean We Should Treat Before the Onset of Disease? (2016) (2)
Plasma VEGF Concentrations after Intravitreous Anti-VEGF Therapy for Diabetic Macular Edema (2019) (2)
Availability of color fundus photographs from previous visit affects practice patterns for patients with diabetes mellitus. (1998) (2)
Death by Gun Violence-A Public Health Crisis. (2017) (2)
Equity and the JAMA Network. (2021) (2)
Patient-reported outcomes among sham vs no-treatment controls from randomized trials. (2011) (2)
Update on the diabetic retinopathy clinical research network (2008) (2)
Preferential Hyperacuity Perimetry Home Monitoring in Patients Following Treatment for Neovascular Age-related Macular Degeneration (2012) (1)
Scleral Cross-Linking in Form-Deprivation Myopic Guinea Pig Eyes Leads to Glaucomatous Changes (2022) (1)
Potential New Non-Invasive Approach for Visualizing Choroidal Neovascularization (2010) (1)
Equity and the JAMA Network. (2021) (1)
Vision Preference Value Scale and Patient Preferences in Choosing Therapy for Symptomatic Vitreomacular Interface Abnormality (2018) (1)
Public Access to Scientific Research Findings and Principles of Biomedical Research-A New Policy for the JAMA Network. (2022) (1)
Death by Gun Violence-A Public Health Crisis. (2017) (1)
Large Hemorrhages After Photodynamic Therapy with Verteporfin Precluding Follow-Up Treatment Decisions (2003) (1)
Impact of Retinal Anastomosis to the Lesion (RAL, aka RAP) on Verteporfin Therapy in Classic CNV or Occult With No Classic CNV (2005) (1)
Ranibizumab Improves Patient-Reported Near and Distance Vision Activities in Patients With Macular Edema Following Retinal Vein Occlusion (2010) (1)
Evaluation of Visual Acuity Measurements with Standard Luminance Compared with Low Luminance in Eyes with Geographic Atrophy from Age-related Macular Degeneration (2015) (1)
Natural course of occult choroidal neovascularization in patients with age-related macular degeneration (1996) (1)
Changes Over Time of a New Non-Invasive Approach for Tracking Choroidal Neovascularization and Associated Fluid (2010) (1)
Death by Gun Violence-A Public Health Crisis. (2017) (1)
National Eye Institute Visual Function Questionnaire-25 (VFQ) Reading Items Improved Following Ranibizumab Treatment in MARINA and ANCHOR (2009) (1)
Identification and Recognition of Limitations of Retrospective Studies in Select Peer-reviewed Journal (2016) (1)
Reproducibility of Gradings of Retinal Photographs in Eyes with Subfoveal Choroidal Neovascularization and Age-Related Macular Degeneration in the Macular Photocoagulation Study (2008) (1)
Death by Gun Violence-A Public Health Crisis. (2017) (1)
Effect of Azithromycin on Lipid Accumulation in Immortalized Human Meibomian Gland (2014) (1)
Apparent disappearance of choroidal neovascularization after initial photodynamic therapy with verteporfin. (2002) (1)
Optimizing management of diabetic macular edema in Hong Kong: a collaborative position paper (2017) (1)
Baseline Predictors of improvement in self-reported visual function following treatment with ranibizumab in patients with diabetic macular edema (2013) (1)
Reading Functions in One Eye versus Both Eyes Open in Neovascular Age-related Macular Degeneration and Their Associations with Patient Reported Vision-related Function Using NEI VFQ-25 (2014) (1)
Prevention of vision-threatening complications in diabetic retinopathy: two perspectives based on results from the DRCR Retina Network Protocol W and the Regeneron-sponsored PANORAMA (2021) (1)
Public Health Impact of the Age-Related Eye Disease Study (AREDS) Results (2002) (1)
JAMA Ophthalmology: it's not just a new name. (2013) (1)
Long-term Progression of Visual Acuity in Age-related Geographic Atrophy From AMD (2002) (1)
Equity and the JAMA Network. (2021) (1)
AI-based AMD Analysis: A Review of Recent Progress (2018) (1)
A Machine Learning Approach to the Detection of Intermediate Stage of Age-Related Macular Degeneration (2009) (1)
Equity and the JAMA Network. (2021) (1)
Immunogenicity With Ranibizumab Biosimilar SB11 (Byooviz) and Reference Product Lucentis and Association With Efficacy, Safety, and Pharmacokinetics (2022) (1)
Assessment of Cirrus™ OCT Registration in Macular Edema from Diabetes or Retinal Vein Occlusion (2013) (1)
Public Access to Scientific Research Findings and Principles of Biomedical Research-A New Policy for the JAMA Network. (2022) (1)
Baseline Fluorescein Angiographic Findings In Patients With Geographic Atrophy (2002) (1)
OCT vs. Indocyanine Green Angiography Features of Polypoidal Choroidal Vasculopathy. (2017) (1)
Public Access to Scientific Research Findings and Principles of Biomedical Research-A New Policy for the JAMA Network. (2022) (1)
Neovascular Age-Related Macular Degeneration: Rationale for Current Treatment Guidelines (2013) (1)
Public Access to Scientific Research Findings and Principles of Biomedical Research-A New Policy for the JAMA Network. (2022) (1)
The NEI VFQ-25C: Calibrating Items in the National Eye Institute Visual Function Questionnaire-25 to Enable Comparison of Outcome Measures (2022) (1)
Quantifying functional reading independence in geographic atrophy: the FRI Index (2015) (1)
Optical Coherence Tomography Features for Identifying Posttreatment Complete Polypoidal Regression in Polypoidal Choroidal Vasculopathy (2022) (1)
JAMA Ophthalmology Publication Policies and Procedures: Fresh Start for a New Year (2014) (1)
Evaluation of the Traveling Vision Examiner Program in the Submacular Surgery Trials Pilot Study (2005) (1)
Retinitis pigmentosa and retinal neovascularization. (1987) (1)
Patient-reported visual function in central serous retinopathy (2016) (1)
Nutrition and vitamin supplements: Protective for age-related maculopathy (ARM)? (1992) (1)
The Role of Abnormalities in the Anticoagulant and Fibrinolytic Systems in Retinal Vascular Occlusions (1993) (1)
Subfoveal Neovascular Lesions in Age-Related Macular Degeneration-Reply (1993) (1)
Equity and the JAMA Network. (2021) (1)
Sensitivity of Functional Reading Independence (FRI) index to change in size of Geographic Atrophy (2015) (1)
Meeting Report of the Hawali '96 Meeting, Grand Wailea, January 21-26, 1996 (1996) (1)
Optical Coherence Tomography Measurements and Analysis Methods in Optical Coherence Tomography Studies of Diabetic (2009) (1)
Mortality in the Age-Related Eye Disease Study: Associations With Age-Related Macular Degeneration (AMD) (2003) (1)
Preferential Hyperacuity Perimetry Monitoring in Patients During Treatment of Neovascular Age-related Macular Degeneration (2013) (0)
Argon Laser Treatment: Short and Long Term Results of Randomized Clinical Trials (1987) (0)
Equity and the JAMA Network. (2021) (0)
Public Access to Scientific Research Findings and Principles of Biomedical Research-A New Policy for the JAMA Network. (2022) (0)
Assessment of Time-domain and Spectral-domain Ocular Coherence Tomography in the Management of Diabetic Macular Edema with Anti-VEGF Therapy (2012) (0)
Equity and the JAMA Network. (2021) (0)
Retinal characteristics in eyes with pathologic myopia among individuals self-identifying as black. (2023) (0)
Follow-up patterns among patients with treatment-naïve proliferative diabetic retinopathy offered panretinal photocoagulation (2018) (0)
AMD after cataract surgery unclear (2011) (0)
Age-related macular degeneration more severe in whites (1999) (0)
Treatment schedule for choroidal neovascularization with ranibizumab (2010) (0)
Public Access to Scientific Research Findings and Principles of Biomedical Research-A New Policy for the JAMA Network. (2022) (0)
Relationship of Visual Acuity and NEI VFQ-25 Visual Function in Exudative AMD Treatment (2008) (0)
Micronutrient Supplementation Usage Patterns in the Prevention of Advanced Age–related Macular Degeneration Among Patients Receiving Eye Care at a Tertiary Ophthalmic Center (2005) (0)
Post-injection endophthalmitis in eyes receiving vs. not receiving topical antibiotic prophylaxis in Northern Thailand (2018) (0)
Sub-threshold Laser Treatment of Macular Edema in Patients with Diabetes (2012) (0)
Anti-VEGF therapy for diabetic macular edema: An update on clinical trial results (2013) (0)
Patient Reported Vision-related Function in Pattern Dystrophy of the Retinal Pigment Epithelium (2014) (0)
Public Access to Scientific Research Findings and Principles of Biomedical Research-A New Policy for the JAMA Network. (2022) (0)
Scanning laser ophthalmoscope macular perimetry for the evaluation of submacular surgery (1997) (0)
Erratum: Optic nerve avulsion (Archives of Opthalmology (1997) 115 (623- 630) (1997) (0)
JAMA Ophthalmology-The Year in Review, 2017: JAMA Ophthalmology Looks Forward to Continued Globalization in 2018. (2018) (0)
Public Access to Scientific Research Findings and Principles of Biomedical Research-A New Policy for the JAMA Network. (2022) (0)
Patient Perspective of the Burden of RVO: A Qualitative Understanding of Vision Related Functioning and the NEI VFQ-25 (2009) (0)
A Conceptual Framework Of Functional Reading Independence In Geographic Atrophy (2013) (0)
New Membrane Study (2017) (0)
Public Access to Scientific Research Findings and Principles of Biomedical Research-A New Policy for the JAMA Network. (2022) (0)
Retina, The Journal of Retinal and Vitreous Diseases 2017 Scientific Reviewers. (2018) (0)
Choroidal Neovascularizations in Asians (2003) (0)
Age-Related Macular Degeneration and Its Management (2009) (0)
JAMA Ophthalmology-The Year in Review, 2020: Bringing Focus to Randomized Clinical Trials. (2021) (0)
Letter to the EditorAuthor Reply (2007) (0)
Impact of Anti-VEGF Therapy on Visual Impairment from Macular Edema Due to Branch Retinal Vein Occlusion (2013) (0)
Announcing the New JAMAOphthalmology.com. (2016) (0)
Outcome After Exchange Transfusion for Central Retinal Vein Occlusion Associated With Extensive Capillary and Arteriolar Nonperfusion in a Patient With Hemoglobin SS Disease. (2019) (0)
Patients with Neovascular AMD Treated with Ranibizumab Report Improvement in Function and Performing Everyday Activities in the MARINA Study (2011) (0)
Comparison of OCT and Fundus Photographic Assessments of Macular Edema (2005) (0)
AI for medical imaging goes deep (2018) (0)
Improvements in Reading Speed After 6 Months of Ranibizumab Treatment in Bravo and Cruise (2010) (0)
Assessment of Cirrus SD-OCT Registration in Patients with Neovascular Age-related Macular Degeneration (2012) (0)
Equity and the JAMA Network. (2021) (0)
A Standardized Method of Reporting Macular Edema After Cataract Surgery Using Optical Coherence Tomography (2007) (0)
EVALUATING NEW RETINAL IMAGING TECHNIQUES. AUTHOR'S REPLY (1999) (0)
Comparison of Hand-Drawn ILM and RPE Segmentation to the Retinal Segmentation Algorithm of the CirrusTM HD-OCT (2008) (0)
Repeatability and Concordance of Visual Acuity Measured with ETDRS Number, ETDRS Landolt C, and Original ETDRS Alphabet Charts in Normal Eyes or Eyes with Sight-threatening Conditions (2017) (0)
Table. Cases of Endophthalmitis After Intravitreal Injections From Single-Use Vials in the Diabetic Retinopathy Clinical Research Network (2017) (0)
Psychometric performance of the nei VFQ-25: recommendations for a modified version of the 25-item national eye institute questionnaire (NEI VFQ-25) based on rasch analysis using clinical trials data across four retinal diseases (2013) (0)
Relationship Between Reading Items of the National Eye Institute Visual Function Questionnaire-25 (VFQ) and Reading Speed (2009) (0)
Erratum: Retinal arteriolar narrowing and risk of coronary heart disease (Journal of Opthalmology (January 2003) 121 (113-114)) (2003) (0)
The Use of Sham Controls in Clinical Trials--Reply (2010) (0)
Author response: Validation of the National Eye Institute Visual Function Questionnaire-25 (NEIVFQ-25) in age-related macular degeneration. (2012) (0)
Short-term Spectral Domain Optical Coherence Tomography Changes after Phacoemulsification in Eyes with No Pre-operative Macular Pathology (2013) (0)
Training and Certifying Key Clinical Personnel in the Multi-Center, Multi-National Clinical Trials of Verteporfin (2002) (0)
Epithelial-Mesenchymal Transition of Retinal Pigment Epithelium from Different Sources in Vitro (2017) (0)
Death by Gun Violence-A Public Health Crisis. (2017) (0)
Timing of Complete Absence of Polypoidal Lesions on ICG Angiography Following Aflibercept Monotherapy in Polypoidal Choroidal Vasculopathy (2019) (0)
The Functional Reading Independence Index (FRII): A New Measure of Treatment Benefit in Geographic Atrophy (2012) (0)
OPTH_A_236636 1249..1259 (2020) (0)
The Responsiveness of the National Eye Institute Visual Function Questionniare-25 (NEI VFQ-25) to Visual Acuity Gains in Diabetic Macular Edema Patients (2012) (0)
Public Access to Scientific Research Findings and Principles of Biomedical Research-A New Policy for the JAMA Network. (2022) (0)
Equity and the JAMA Network. (2021) (0)
Qualifying to Use a Preferential Hyperacuity Perimetry Home Device Prior to Monitoring for Neovascular Age-related Macular Degeneration (2014) (0)
Psychometric Performance Of The Nei Vfq-25: Rasch Analysis Of The Nei Vfq-25 As A Measure Of Patient-Reported Visual Function Across Four Retinal Diseases (2013) (0)
Identification of Two Potentially Novel Mutations in X-linked Juvenile Retinoschisis (2017) (0)
Variability Between Trained Experts Performing Hand-Drawn Segmentations of CirrusTm HD-OCT Scans (2008) (0)
Reading speed in geographic atrophy: Change over time and relation to patient-reported functioning (2015) (0)
Reliability and Construct Validity of National Eye Institute Visual Function Questionnaire-25 in Geographic Atrophy (2016) (0)
JAMA Ophthalmology Year in Review, 2016. (2017) (0)
Longer Term Safety Outcomes (4 or More Years) After Initiating Anti-Vascular Endothelial Growth Factor Therapy for Neovascular Age-related Macular Degeneration (2013) (0)
The health-related quality-of-life impact of late-stage age-related macular degeneration (1998) (0)
Treatment of Subfoveal Choroidal Neovascularization-Reply (1995) (0)
Comparative quantification of geographic atrophy of the retinal pigment epithelium across color fundus photographs, red-free fundus photographs, and autofluorescence imaging by grader versus automated grading software using optical coherence tomography (2015) (0)
Introduction: Vascular endothelial growth factor blockade for retinal diseases: The 2009 update (2010) (0)
Public Access to Scientific Research Findings and Principles of Biomedical Research-A New Policy for the JAMA Network. (2022) (0)
Restrictions on Use of Prescribing Data for Drug Promotion (2012) (0)
Patient Use of Dietary Supplements, Home Monitoring, or Genetic Testing for Nonneovascular Age-Related Macular Degeneration (2021) (0)
Analysis of Macular Edema After Cataract Surgery in Diabetics With Optical Coherence Tomography (2006) (0)
Safely Viewing Solar Eclipses. (2017) (0)
Correlation of Change in Macular Thickness With Change in Visual Acuity in Diabetic Macular Edema: Post Hoc Analysis of VISTA and VIVID Trials (2022) (0)
Polypoidal Choroidal Vasculopathy Based on Non-ICGA Criteria In White Patients With Neovascular Age-Related Macular Degeneration. (2022) (0)
Correlation between change in central subfield thickness and change in visual acuity in macular edema due to retinal vein occlusion: post hoc analysis of COPERNICUS, GALILEO, and VIBRANT (2022) (0)
Artificial Intelligence, Machine Learning and Deep Learning in Ophthalmology: Current Clinical Relevance (2019) (0)
Observational study of subclinical diabetic macular edema (2012) (0)
Comparison of monocular fundus photography with optical coherence tomography for identifying diabetic macular edema (2015) (0)
Profile of a potential treatment for geographic atrophy: An in-depth look at a complement-targeted therapy (2015) (0)
Long-term quality of life and visual functioning in patients in the macular photocoagulation study: A pilot study (1996) (0)
Preferential Hyperacuity Perimetry Home Monitoring in Patients at High Risk or Following Treatment for Neovascular Age-related Macular Degeneration (2011) (0)
Express Medicine-Potential for Home-Based Medical Care. (2021) (0)
Qualifying to Use a HomeMonitoring Device for Detection of Neovascular Age-RelatedMacular Degeneration (2015) (0)
What Artificial Intelligence Chatbots Mean for Editors, Authors, and Readers of Peer-Reviewed Ophthalmic Literature. (2023) (0)
Vulnerable populations in the underuse of the US Health Care System by persons with diabetes mellitus and diabetic macular edema-reply. (2014) (0)
Automatic Retinal Imaging and Analysis: Age-Related Macular Degeneration (AMD) within Age-Related Eye Disease Studies (AREDS) (2021) (0)
Cystoid macular edema from niacin typically is not accompanied by fluorescein leakage on angiography. Author's replay (2005) (0)
Fluctuating central subfield thickness (2014) (0)
Outcome Measures. Authors' reply (2008) (0)
Five-year follow-up of fellow eyes with ocular histoplasmosis and unilateral extrafoveal or juxtafoveal choroidal neovascularization (CNV) (1996) (0)
Expanded Understanding of Retinal Abnormalities Overlying Choroidal Neovascularization Noted in Minimum Intensity Projection Images (MinIP) from CirrusTM SD-OCT in Patients with Age-related Macular Degeneration (2011) (0)
Reliability and Convergent Validity of The Nei Vfq-25 with and Without Near and Distance Activity Appendix Items In Patients with Geographic Atrophy (GA) Secondary to Age Related Macular Degeneration (AMD) (2016) (0)
Impact of Cataract Surgery on Progression of Geographic Atrophy in Age-Related Macular Degeneration (2009) (0)
Cases of Legal Blindness and Visual Impairment Avoided Using Ranibizumab for Diabetic Macular Edema in the United States (2012) (0)
Public Access to Scientific Research Findings and Principles of Biomedical Research-A New Policy for the JAMA Network. (2022) (0)
Grading CMV Retinitis Progression Compared Between Two Reading Centers (2003) (0)
Controversies in Using Off-Label Intravitreous Bevacizumab for Patients With Diabetic Macular Edema-Reply. (2017) (0)
Announcing the 150th Anniversary of JAMA Ophthalmology-Sesquicentennial, 1869 to 2019. (2019) (0)
JAMA Ophthalmology-The Year in Review, 2022: Continued Evolution for Readers, Authors, and Editors. (2023) (0)
Towards Automated Assessment of AREDS Severity Scale and Simple Scale Using RTVue® Spectral Domain Optical Coherence Tomography Tools (2013) (0)
Diabetic Retinopathy and Its Management (2009) (0)
Comparative Effectiveness Trial for Diabetic Macular Edema: Three Comparisons for the Price of One Study (2017) (0)
Repeatability Of Retinal Thickness Measurements Using CirrusTm HD-OCT (2008) (0)
TREATMENT OF SUBFOVEAL CHOROIDAL NEOVASCULARIZATION. AUTHORS' REPLY (1995) (0)
Relative contributions of reduced vision and general health to NEI-VFQ scores in patients with neovascular age-related macular degeneration (2004) (0)
Age-Related Macular Degeneration (AMD): Non-neovascular and Neovascular AMD (2020) (0)
Treatment of Proliferative Diabetic Retinopathy with Intravitreous Injection of Ranibizumab (2015) (0)
CHOROIDAL NEOVASCULARIZATION: OTHER CLINICAL TRIAL OUTCOMES * (2005) (0)
Pattern Dystrophy of the Retinal Pigment Epithelium Misdiagnosed as Age-related Macular Degeneration (2014) (0)
Death by Gun Violence-A Public Health Crisis. (2017) (0)
Sensitivity and Specificity of Clinically Relevant Features on Fundus Photography, Optical Coherence Tomography, and Fluorescein Angiography to Diagnose Polypoidal Choroidal Vasculopathy (2018) (0)
JAMA Ophthalmology-The Year in Review, 2018: Embrace the Change, Maintain the Core. (2019) (0)
Partial Ablation of Neovascular Membranes Involving the Fovea-Reply (1989) (0)
Photodvnamic tlieiapy for choioidal neovasculansation m a phase I/I I study prelimmarv results of multiple treatments (1997) (0)
Visual acuity time in range: a novel concept to describe consistency in treatment response in diabetic macular oedema. (2023) (0)
An Intelligent Pen-Based Ophthalmologic Patient Record (1995) (0)
JAMA Ophthalmology-The Year in Review, 2021: Fact and Opinion. (2022) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Neil M. Bressler?

Neil M. Bressler is affiliated with the following schools:

Johns Hopkins University

Neil M. Bressler's Academic­Influence.com Rankings

Why Is Neil M. Bressler Influential?

Neil M. Bressler's Published Works

Published Works

What Schools Are Affiliated With Neil M. Bressler?

Neil M. Bressler's AcademicInfluence.com Rankings